LT3394053T - (4-hidriksi-2-fenil-1,3-tiazol-5-il)metanono dariniai kaip trpm8 antagonistai - Google Patents

(4-hidriksi-2-fenil-1,3-tiazol-5-il)metanono dariniai kaip trpm8 antagonistai

Info

Publication number
LT3394053T
LT3394053T LT16823231T LT16823231T LT3394053T LT 3394053 T LT3394053 T LT 3394053T LT 16823231 T LT16823231 T LT 16823231T LT 16823231 T LT16823231 T LT 16823231T LT 3394053 T LT3394053 T LT 3394053T
Authority
LT
Lithuania
Prior art keywords
thiazol
hydroxy
phenyl
methanone derivatives
trpm8 antagonists
Prior art date
Application number
LT16823231T
Other languages
English (en)
Inventor
Andrea Aramini
Gianluca Bianchini
Samuele Lillini
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of LT3394053T publication Critical patent/LT3394053T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355Non-condensed oxazines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LT16823231T 2015-12-21 2016-12-16 (4-hidriksi-2-fenil-1,3-tiazol-5-il)metanono dariniai kaip trpm8 antagonistai LT3394053T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15201788.5A EP3184524A1 (en) 2015-12-21 2015-12-21 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists
PCT/EP2016/081567 WO2017108632A1 (en) 2015-12-21 2016-12-16 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists

Publications (1)

Publication Number Publication Date
LT3394053T true LT3394053T (lt) 2019-12-10

Family

ID=54883947

Family Applications (1)

Application Number Title Priority Date Filing Date
LT16823231T LT3394053T (lt) 2015-12-21 2016-12-16 (4-hidriksi-2-fenil-1,3-tiazol-5-il)metanono dariniai kaip trpm8 antagonistai

Country Status (20)

Country Link
US (1) US10246448B2 (lt)
EP (2) EP3184524A1 (lt)
JP (1) JP6908610B2 (lt)
KR (1) KR102681427B1 (lt)
CN (1) CN108699053B (lt)
AU (1) AU2016378108B9 (lt)
CY (1) CY1122312T1 (lt)
DK (1) DK3394053T3 (lt)
EA (1) EA037845B1 (lt)
ES (1) ES2757324T3 (lt)
HK (1) HK1257896B (lt)
HR (1) HRP20192008T1 (lt)
HU (1) HUE046284T2 (lt)
LT (1) LT3394053T (lt)
PT (1) PT3394053T (lt)
RS (1) RS59475B1 (lt)
SI (1) SI3394053T1 (lt)
SM (1) SMT201900644T1 (lt)
WO (1) WO2017108632A1 (lt)
ZA (1) ZA201803300B (lt)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2015531A (en) 1932-07-25 1935-09-24 Champion Paper & Fibre Co Roll coating machine
WO2006040136A1 (en) 2004-10-13 2006-04-20 Bayer Healthcare Ag Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder
WO2007017094A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted benzyloxy-phenylmethylcarbamate derivatives
WO2007017093A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 2-benzyloxy-benzoic acid amide derivatives
WO2007017092A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 4-benzyloxy-benzoic acid amide derivatives
WO2007080109A1 (en) 2006-01-16 2007-07-19 Bayer Healthcare Ag Substituded benzyloxy-phenylmethylurea derivatives
JP5404388B2 (ja) 2006-05-10 2014-01-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 冷メントール受容体−1拮抗薬
AR067602A1 (es) 2007-07-18 2009-10-14 Janssen Pharmaceutica Nv Sulfonamida como moduladores del trpm8
WO2010103381A1 (en) 2009-03-13 2010-09-16 Glenmark Pharmaceuticals S.A. Spirocyclic piperidine derivatives as trpm 8 modulators
FR2943672B1 (fr) * 2009-03-27 2011-03-25 Sanofi Aventis Derives de 3-alcoxy-4,5-diarylthiophene-2-carboxamide,leur preparation et leur application en therapeutique.
EP2424517A4 (en) 2009-05-01 2013-01-23 Raqualia Pharma Inc SULFAMOYLBENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS
WO2011109551A2 (en) * 2010-03-03 2011-09-09 Calcimedica Inc. Compounds that modulate intracellular calcium
ES2377785B2 (es) 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
EP2481727A1 (en) * 2011-01-28 2012-08-01 Dompe S.p.A. TRPM8 receptor antagonists
RS57389B1 (sr) * 2011-12-19 2018-09-28 Dompe Farm Spa Antagonisti trpm8
EP2995611B1 (en) * 2013-05-08 2017-10-11 Kissei Pharmaceutical Co., Ltd. Alpha-substituted glycineamide derivative
RS58590B1 (sr) * 2014-06-23 2019-05-31 Dompe Farm Spa Derivati 2-aril-4-hidroksi-1,3-tiazola korisni kao inhibitori trpm8 u lečenju neuralgije, bola, copd i astme

Also Published As

Publication number Publication date
ES2757324T3 (es) 2020-04-28
JP6908610B2 (ja) 2021-07-28
CN108699053B (zh) 2022-01-14
JP2018538334A (ja) 2018-12-27
EP3394053B1 (en) 2019-08-21
CY1122312T1 (el) 2021-01-27
AU2016378108A1 (en) 2018-06-21
WO2017108632A1 (en) 2017-06-29
AU2016378108B9 (en) 2021-01-28
EA037845B1 (ru) 2021-05-27
HK1257896B (en) 2020-06-19
SMT201900644T1 (it) 2020-01-14
DK3394053T3 (da) 2019-11-18
US10246448B2 (en) 2019-04-02
RS59475B1 (sr) 2019-12-31
EA201891503A1 (ru) 2019-01-31
KR20180095818A (ko) 2018-08-28
HRP20192008T1 (hr) 2020-02-07
KR102681427B1 (ko) 2024-07-05
US20180319785A1 (en) 2018-11-08
HUE046284T2 (hu) 2020-02-28
EP3394053A1 (en) 2018-10-31
CN108699053A (zh) 2018-10-23
EP3184524A1 (en) 2017-06-28
PT3394053T (pt) 2019-10-31
SI3394053T1 (sl) 2019-12-31
ZA201803300B (en) 2019-07-31
AU2016378108B2 (en) 2020-12-17

Similar Documents

Publication Publication Date Title
LT3580220T (lt) Aminotriazolopiridinai, kaip kinazės inhibitoriai
LT3377488T (lt) Heterocikliniai junginiai, kaip imunomoduliatoriai
LT3371190T (lt) Heterocikliniai junginiai, kaip pi3k-gama inhibitoriai
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3201196T3 (da) Kondenserede, pentacykliske imidazolderivater
DK3355884T3 (da) Tetrahydro-1h-pyrido[3,4-b]indol-antiøstrogenlægemidler
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
LT3386991T (lt) Policikliniai junginiai, kaip brutono tirozinkinazės inhibitoriai
LT3704118T (lt) Aminoimidazopiridazinai, kaip kinazės inhibitoriai
LT3168219T (lt) Piridono dariniai, turintys tetrahidropiranilmetilo grupę
DK3319597T3 (da) Sammensætninger, der omfatter antistof-duocarmycin-lægemiddelkonjugater
BR112017001387A2 (pt) alargador.
EP2975030A4 (en) Dihydropyridazine-3,5-dione derivative
BR112017001389A2 (pt) alargador.
LT3371168T (lt) Indolin-2-ono dariniai
BR112017001388A2 (pt) alargador.
BR112017001386A2 (pt) alargador.
HUE050667T2 (hu) Új 5-HT2 antagonisták
DK3368519T3 (da) Hidtil ukendte, heterocykliske antiøstrogener
LT3253749T (lt) Junginiai, pasižymintys priešnavikiniu aktyvumu
LT3389633T (lt) Farmacinės kompozicijos, apimančios fenilaminopirimidino darinį
LT3233862T (lt) Imidazopiridazino dariniai, kaip pi3kbeta slopikliai
IT201600102119A1 (it) Seminatrice
DK3310756T3 (da) Thromboxanreceptorantagonister
HUE055481T2 (hu) Szintbe foglaló, tárgytartó rögzítõelem